Elzonris
Term · Oncology and biomedicine · MLC-T-ONC-002758
A drug used to treat adults and children aged 2 years and older with a rare blood cancer called blastic plasmacytoid dendritic cell neoplasm. It is also being studied in the treatment of other types of cancer. Elzonris is made up of interleukin-3 (IL-3), which binds to an IL-3 receptor protein called CD123. CD123 may be found in higher than normal amounts on some types of cancer cells. Elzonris is also made up of a diphtheria toxin, which may help kill cancer cells. Elzonris is a type of cytotoxin. Also called tagraxofusp.
| Identifier | MLC-T-ONC-002758 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | tagraxofusp |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002758",
"term": "Elzonris",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults and children aged 2 years and older with a rare blood cancer called blastic plasmacytoid dendritic cell neoplasm. It is also being studied in the treatment of other types of cancer. Elzonris is made up of interleukin-3 (IL-3), which binds to an IL-3 receptor protein called CD123. CD123 may be found in higher than normal amounts on some types of cancer cells. Elzonris is also made up of a diphtheria toxin, which may help kill cancer cells. Elzonris is a type of cytotoxin. Also called tagraxofusp.",
"synonyms": [
"tagraxofusp"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/elzonris/"
}
Record 6,565 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.